JMP Securities Boosts Option Care Health (NASDAQ:OPCH) Price Target to $37.00

Option Care Health (NASDAQ:OPCH) had its price objective raised by equities research analysts at JMP Securities from $36.00 to $37.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has a “market outperform” rating on the stock. JMP Securities’ price target would suggest a potential upside of 18.89% from the company’s current price.

Separately, Barrington Research boosted their target price on shares of Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a report on Thursday, August 1st.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded down $0.30 during trading on Monday, hitting $31.12. 54,106 shares of the company were exchanged, compared to its average volume of 1,385,923. Option Care Health has a 1-year low of $26.11 and a 1-year high of $34.63. The company has a market capitalization of $5.41 billion, a P/E ratio of 20.47, a price-to-earnings-growth ratio of 2.42 and a beta of 1.29. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. The business’s 50 day moving average is $31.29 and its 200-day moving average is $30.40.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.03. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the prior year, the firm posted $0.63 earnings per share. The firm’s revenue was up 14.8% compared to the same quarter last year. Equities analysts forecast that Option Care Health will post 1.22 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Parallel Advisors LLC grew its holdings in Option Care Health by 130.2% during the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after buying an additional 478 shares in the last quarter. TFO Wealth Partners LLC boosted its stake in Option Care Health by 24,625.0% during the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock valued at $33,000 after buying an additional 985 shares during the period. Park Place Capital Corp grew its position in Option Care Health by 48.4% during the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after buying an additional 372 shares in the last quarter. Blue Trust Inc. grew its position in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after buying an additional 377 shares in the last quarter. Finally, SageView Advisory Group LLC bought a new position in Option Care Health in the 1st quarter worth about $85,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.